Physician profile
Samir K Patel
NPI 1356526917
$11,290.79
in general payments reported to CMS, 2019-2025
40 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,792 · 2020: $1,480 · 2021: $1,818 · 2022: $1,789 · 2023: $1,545 · 2024: $1,586 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,412.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,134.93 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $1,380.57 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $1,069.50 | 2020-2024 | Senza |
| Horizon Therapeutics Plc | $787.28 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $682.84 | 2019-2024 | Belbuca |
| Globus Medical, INC. | $441.35 | 2025 | Senza, Omnia, Vyrsa V1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $353.16 | 2019-2024 | Relistor |
| Abbvie INC. | $327.94 | 2021-2024 | |
| Boston Scientific Corporation | $309.76 | 2021-2024 | |
| Allergan, INC. | $227.88 | 2020-2021 | |
| Stryker Corporation | $218.32 | 2023-2025 | Omnicurve, Spinejack, Mild Device Kit |
| Ipsen Biopharmaceuticals, INC | $209.23 | 2019-2023 | Dysport |
| Merz Pharmaceuticals, LLC | $185.71 | 2022-2025 | Xeomin |
| Si-Bone, INC. | $179.05 | 2019 | |
| Spinal Simplicity, LLC | $160.24 | 2023 | Ha Minuteman G3-R |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.